DOCS: Doximity Inc Class A

DOCS新闻

• 15:02 OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
• 14:40 OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
• 12:46 OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
• 00:07 Another Wall Street analyst slashes Doximity stock price outlook
• 15:40 DOCS vs. HIMS: Which Stock Is the Better Value Option?
• 15:31 DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
• 14:15 HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell?
• 14:09 OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
• 13:35 Down 25.7% in 4 Weeks, Here's Why Doximity (DOCS) Looks Ripe for a Turnaround
• 10:36 S&P Futures Plunge as Inflation Fears Push Bond Yields Higher
• 20:35 Stocks Settle Higher on Strong Tech Earnings and Economic Resilience
• 15:43 Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
• 15:23 S&P 500 and Nasdaq 100 Post Record Highs on Tech Strength
• 14:05 Doximity, 'LinkedIn For Doctors,' Hits A Record Low On AI Growing Pains
• 14:03 Stocks Push Higher on Strength in Tech and a Solid US Retail Sales Report
• 13:13 These Analysts Slash Their Forecasts On Doximity After Q4 Results - Doximity (NYSE:DOCS)
• 10:37 Stocks Rise Before the Open as Tech Rally Rolls On, U.S. Retail Sales Data and Trump-Xi Summit in Focus